Immune checkpoint inhibitor– and phosphatidylinositol-3-kinase inhibitor–related diabetes induced by antineoplastic drugs: two case reports and a literature review

Immune checkpoint inhibitor (ICI)- and phosphatidylinositol-3-kinase inhibitor (PI3Ki)-related diabetes mellitus are common side effects of anti-tumor drug use that present mainly as hyperglycemia. Here, we present two case reports of diabetes mellitus caused by the use of tremelimumab and apalutami...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yue, Zhong, Mingyao, Gan, Lulu, Xiang, Cheng, Li, Ling, Yan, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509015/
https://www.ncbi.nlm.nih.gov/pubmed/37732122
http://dx.doi.org/10.3389/fendo.2023.1236946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509015/
https://www.ncbi.nlm.nih.gov/pubmed/37732122
http://dx.doi.org/10.3389/fendo.2023.1236946

Ejemplares similares